Clinical Trials Browser

Phase 1/2 × Peripheral Blood Stem Cell Transplantation × ruxolitinib × Clear all

NCT04582604 2020-10-20

Ruxolitinib and Decitabine for High Risk Hematological Malignancies

Phase 1/2 Unknown

Peripheral Blood Stem Cell Transplantation